Ali-Erdem M, Burak-Cankaya A, Cemil-Isler S, Demircan S, Soluk M, Kasapoglu C, Korhan-Oral C. Extraction socket healing in rats treated with bisphosphonate: Animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients. Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16 (7):e879-83.

doi:10.4317/medoral.17150

http://dx.doi.org/doi:10.4317/medoral.17150

1. Rogers MJ, Watts DJ, Russell RG. Overview of bisphosphonates. Cancer. 1997;80:1652-60.
http://dx.doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z

2. Coleman RE. Future directions in the treatment and prevention of bone metastases. Am J Clin Oncol. 2002;25:S32-8.
http://dx.doi.org/10.1097/00000421-200212001-00006
PMid:12562049

3. Holen I, Coleman RE. Bisphosphonates as treatment of bone metastases. Curr Pharm Des. 2010;16:1262-71.
http://dx.doi.org/10.2174/138161210791034003
PMid:20166976

4. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1

5. Hansen T, Kunkel M, Weber A, James Kirkpatrick C. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med. 2006;35:155-60.
http://dx.doi.org/10.1111/j.1600-0714.2006.00391.x
PMid:16454811

6. Flichy-Fernández AJ, Balaguer-Martínez J, Peñarrocha-Diago M, Bagán JV. Bisphosphonates and dental implants: current problems. Med Oral Patol Oral Cir Bucal. 2009;14:E355-60.
PMid:19561566

7. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-410.
http://dx.doi.org/10.1016/j.joms.2007.08.003
PMid:18022461

8. Pérez SB, Barrero MV, Hernández MS, Knezevic M, Navarro JM, Millares JR. Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative treatment. Med Oral Patol Oral Cir Bucal. 2008;13:E770-3.
PMid:19047964

9. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-34.
http://dx.doi.org/10.1016/j.joms.2004.02.004
PMid:15122554

10. Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000;15:613-20.
http://dx.doi.org/10.1359/jbmr.2000.15.4.613
PMid:10780852

11. Zaki Ae, Vanhuysen G. Histology of the periodontium following tooth movement. J Dent Res. 1963;42:1373-9.
http://dx.doi.org/10.1177/00220345630420061401
PMid:14081960

12. Rygh P. Ultrastructural changes in pressure zones of human periodontium incident to orthodontic tooth movement. Acta Odontol Scand. 1973;31:109-22.
http://dx.doi.org/10.3109/00016357309004617
PMid:4516276

13. Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302:1055-61.
http://dx.doi.org/10.1124/jpet.102.035295
PMid:12183663

14. Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res. 2002;62:6538-44.
PMid:12438248

15. Pietrokovski J, Massler M. Ridge remodeling after tooth extraction in rats. J Dent Res. 1967;46:222-31.
http://dx.doi.org/10.1177/00220345670460011501
PMid:5226389

16. Johansen JR. Repair of the post-extraction alveolus in the Wistar rat. A histologic and autoradiographic study. Acta Odontol Scand. 1970;28:441-61.
http://dx.doi.org/10.3109/00016357009028237
PMid:5271258

17. Hikita H, Miyazawa K, Tabuchi M, Kimura M, Goto S. Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats. J Bone Miner Metab. 2009;27:663-72.
http://dx.doi.org/10.1007/s00774-009-0090-6
PMid:19436946

18. Yamamoto Y, Udagawa N, Matsuura S, Nakamichi Y, Horiuchi H, Hosoya A, et al. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand. Endocrinology. 2006;147:3366-74.
http://dx.doi.org/10.1210/en.2006-0216
PMid:16627581

19. Tabuchi M, Miyazawa K, Kimura M, Maeda H, Kawai T, Kameyama Y, et al. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice. Calcif Tissue Int. 2005;77:239-49.
http://dx.doi.org/10.1007/s00223-004-0223-9
PMid:16193235

20. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone. 2007;41:318-20.
http://dx.doi.org/10.1016/j.bone.2007.04.196
PMid:17572168

21. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol. 2009;45:164-72.
http://dx.doi.org/10.1016/j.oraloncology.2008.04.013
PMid:18715819